LaRue-Nolan K, Raja Arul G, Sigafoos A, Shi J, Fernandez-Zapico M
Biochem J. 2024; 481(15):983-997.
PMID: 39078225
PMC: 11332384.
DOI: 10.1042/BCJ20230374.
Serebreni L, Pleyer L, Haberle V, Hendy O, Vlasova A, Loubiere V
EMBO J. 2023; 42(10):e113519.
PMID: 37013908
PMC: 10183819.
DOI: 10.15252/embj.2023113519.
Oelschlager L, Stahl P, Kaschani F, Stauber R, Knauer S, Hensel A
Cells. 2023; 12(3).
PMID: 36766705
PMC: 9913075.
DOI: 10.3390/cells12030363.
Hoing A, Struth R, Beuck C, Rafieiolhosseini N, Hoffmann D, Stauber R
RSC Adv. 2022; 12(53):34176-34184.
PMID: 36545626
PMC: 9709806.
DOI: 10.1039/d2ra06019a.
Hensel A, Stahl P, Moews L, Konig L, Patwardhan R, Hoing A
iScience. 2022; 25(6):104355.
PMID: 35601920
PMC: 9121324.
DOI: 10.1016/j.isci.2022.104355.
Suleiman-El-Hattab syndrome: a histone modification disorder caused by TASP1 deficiency.
Riedhammer K, Burgemeister A, Cantagrel V, Amiel J, Siquier-Pernet K, Boddaert N
Hum Mol Genet. 2022; 31(18):3083-3094.
PMID: 35512351
PMC: 9476618.
DOI: 10.1093/hmg/ddac098.
Closantel is an allosteric inhibitor of human Taspase1.
Luciano V, Proschak E, Langer J, Knapp S, Heering J, Marschalek R
iScience. 2021; 24(12):103524.
PMID: 34934933
PMC: 8661544.
DOI: 10.1016/j.isci.2021.103524.
Taspase1 orchestrates fetal liver hematopoietic stem cell and vertebrae fates by cleaving TFIIA.
Niizuma H, Searleman A, Takeda S, Armstrong S, Park C, Cheng E
JCI Insight. 2021; 6(15).
PMID: 34156981
PMC: 8410044.
DOI: 10.1172/jci.insight.149382.
Therapeutic strategies against hDOT1L as a potential drug target in MLL-rearranged leukemias.
Banday S, Farooq Z, Ganai S, Altaf M
Clin Epigenetics. 2020; 12(1):73.
PMID: 32450905
PMC: 7249331.
DOI: 10.1186/s13148-020-00860-2.
Site-specific proteolytic cleavage prevents ubiquitination and degradation of human REV3L, the catalytic subunit of DNA polymerase ζ.
Wang F, Li P, Shao Y, Li Y, Zhang K, Li M
Nucleic Acids Res. 2020; 48(7):3619-3637.
PMID: 32064513
PMC: 7144948.
DOI: 10.1093/nar/gkaa096.
TASP1 mutation in a female with craniofacial anomalies, anterior segment dysgenesis, congenital immunodeficiency and macrocytic anemia.
Balkin D, Poranki M, Forester C, Dorsey M, Slavotinek A, Pomerantz J
Mol Genet Genomic Med. 2019; 7(9):e818.
PMID: 31350873
PMC: 6732342.
DOI: 10.1002/mgg3.818.
Regulation of MLL/COMPASS stability through its proteolytic cleavage by taspase1 as a possible approach for clinical therapy of leukemia.
Zhao Z, Wang L, Volk A, Birch N, Stoltz K, Bartom E
Genes Dev. 2018; 33(1-2):61-74.
PMID: 30573454
PMC: 6317322.
DOI: 10.1101/gad.319830.118.
A Strategy To Isolate Modifiers of Lethal Mutations: Investigating the Endoderm Specifying Ability of the Intestinal Differentiation GATA Factor ELT-2.
Wiesenfahrt T, Duanmu J, Snider F, Moerman D, Au V, Li-Leger E
G3 (Bethesda). 2018; 8(5):1425-1437.
PMID: 29593072
PMC: 5940137.
DOI: 10.1534/g3.118.200079.
Disease-relevant signalling-pathways in head and neck cancer: Taspase1's proteolytic activity fine-tunes TFIIA function.
Gribko A, Hahlbrock A, Strieth S, Becker S, Hagemann J, Deichelbohrer M
Sci Rep. 2017; 7(1):14937.
PMID: 29097782
PMC: 5668323.
DOI: 10.1038/s41598-017-14814-x.
A transcription factor IIA-binding site differentially regulates RNA polymerase II-mediated transcription in a promoter context-dependent manner.
Wang J, Zhao S, He W, Wei Y, Zhang Y, Pegg H
J Biol Chem. 2017; 292(28):11873-11885.
PMID: 28539359
PMC: 5512080.
DOI: 10.1074/jbc.M116.770412.
TRF2 is recruited to the pre-initiation complex as a testis-specific subunit of TFIIA/ALF to promote haploid cell gene expression.
Martianov I, Velt A, Davidson G, Choukrallah M, Davidson I
Sci Rep. 2016; 6:32069.
PMID: 27576952
PMC: 5006001.
DOI: 10.1038/srep32069.
Taspase 1: A protease with many biological surprises.
Niizuma H, Cheng E, Hsieh J
Mol Cell Oncol. 2016; 2(4):e999513.
PMID: 27308523
PMC: 4905357.
DOI: 10.1080/23723556.2014.999513.
Structural Characterization of the Loop at the Alpha-Subunit C-Terminus of the Mixed Lineage Leukemia Protein Activating Protease Taspase1.
Boom J, Trusch F, Hoppstock L, Beuck C, Bayer P
PLoS One. 2016; 11(3):e0151431.
PMID: 26974973
PMC: 4790943.
DOI: 10.1371/journal.pone.0151431.
Taspase1: a 'misunderstood' protease with translational cancer relevance.
Wunsch D, Hahlbrock A, Jung S, Schirmeister T, van den Boom J, Schilling O
Oncogene. 2015; 35(26):3351-64.
PMID: 26657154
DOI: 10.1038/onc.2015.436.
Unraveling the Activation Mechanism of Taspase1 which Controls the Oncogenic AF4-MLL Fusion Protein.
Sabiani S, Geppert T, Engelbrecht C, Kowarz E, Schneider G, Marschalek R
EBioMedicine. 2015; 2(5):386-95.
PMID: 26137584
PMC: 4486195.
DOI: 10.1016/j.ebiom.2015.04.009.